Future directions of postoperative spinal implant infections.
暂无分享,去创建一个
[1] Lauren N. Pearson,et al. Letter to the Editor on "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". , 2020, The Journal of arthroplasty.
[2] V. Goel,et al. A Multicenter Trial Demonstrating Presence or Absence of Bacterial Contamination at the Screw-Bone Interface Owing to Absence or Presence of Pedicle Screw Guard, Respectively, During Spinal Fusion , 2020, Clinical spine surgery.
[3] Jeffrey C. Wang,et al. Updates on Evidence-Based Practices to Reduce Preoperative and Intraoperative Contamination of Implants in Spine Surgery: A Narrative Review , 2019, Spine surgery and related research.
[4] Samuel K. Cho,et al. Biomaterials in Spinal Implants: A Review , 2019, Neurospine.
[5] P. Severi,et al. Infection with Spinal Instrumentation: A 20-Year, Single-Institution Experience with Review of Pathogenesis, Diagnosis, Prevention, and Management , 2019, Asian journal of neurosurgery.
[6] C. Perka,et al. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa , 2019, Antimicrobial Agents and Chemotherapy.
[7] L. Domachevsky,et al. The Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Diagnosis of Postoperative Hardware-Related Spinal Infections. , 2019, The Israel Medical Association journal : IMAJ.
[8] P. Vajkoczy,et al. High frequency of low-virulent microorganisms detected by sonication of pedicle screws: a potential cause for implant failure. , 2019, Journal of neurosurgery. Spine.
[9] Jeffrey C. Wang,et al. Harboring Contaminants in Repeatedly Reprocessed Pedicle Screws , 2018, Global spine journal.
[10] Jun S. Kim,et al. Postoperative Spine Infection: Diagnosis and Management , 2018, Global spine journal.
[11] Antonia F. Chen,et al. What Markers Best Guide the Timing of Reimplantation in Two-stage Exchange Arthroplasty for PJI? A Systematic Review and Meta-analysis , 2018, Clinical orthopaedics and related research.
[12] A. Leithner,et al. Pedicle screw loosening is correlated to chronic subclinical deep implant infection: a retrospective database analysis , 2018, European Spine Journal.
[13] J. Parvizi,et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. , 2018, The Journal of arthroplasty.
[14] S. Shivaswamy,et al. A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia , 2018, PloS one.
[15] H. Abdelbary,et al. Current review—The rise of bacteriophage as a unique therapeutic platform in treating peri‐prosthetic joint infections , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[16] R. G. Richards,et al. Infection after fracture fixation: Current surgical and microbiological concepts. , 2016, Injury.
[17] Asad U. Khan,et al. Nano-therapeutics: A revolution in infection control in post antibiotic era. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[18] A. Benditz,et al. Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study , 2017, Drug design, development and therapy.
[19] D. Monti,et al. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] P. Kubes,et al. Br Ief Definitive Repor T Identification and Treatment of the Staphylococcus Aureus Reservoir in Vivo , 2022 .
[21] Alan H. Daniels,et al. Antimicrobial technology in orthopedic and spinal implants. , 2016, World journal of orthopedics.
[22] Lorena Rodríguez-Rubio,et al. Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry , 2016, Front. Microbiol..
[23] Q. Guo,et al. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice , 2016, PloS one.
[24] Y. Carmeli,et al. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. , 2016, The Journal of antimicrobial chemotherapy.
[25] M. Rybak,et al. Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections , 2016, Infectious Diseases and Therapy.
[26] Nicole R. Luke-Marshall,et al. Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model , 2016, Clinical orthopaedics and related research.
[27] G. Nath,et al. Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model , 2016, The Indian journal of medical research.
[28] P. S. Andersen,et al. Novel antibody–antibiotic conjugate eliminates intracellular S. aureus , 2015, Nature.
[29] Peter C. Fineran,et al. A century of the phage: past, present and future , 2015, Nature Reviews Microbiology.
[30] D. Lehoux,et al. Oritavancin Pharmacokinetics and Bone Penetration in Rabbits , 2015, Antimicrobial Agents and Chemotherapy.
[31] R. Hancock,et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. , 2015, Chemistry & biology.
[32] Nicole R. Luke-Marshall,et al. Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for methicillin-resistant Staphylococcus aureus periprosthetic infections. , 2015, Biomaterials.
[33] J. Baldassarre,et al. Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue , 2015, Antimicrobial Agents and Chemotherapy.
[34] A. Bahar,et al. Antimicrobial Peptides , 2013, Pharmaceuticals.
[35] Lee A. Tan,et al. Infection with spinal instrumentation: Review of pathogenesis, diagnosis, prevention, and management , 2013, Surgical neurology international.
[36] A. Quaile. Infections associated with spinal implants , 2012, International Orthopaedics.
[37] I. Sia,et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[38] Eve Neesham-Grenon,et al. Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro , 2008, Antimicrobial Agents and Chemotherapy.
[39] C. Van de Wiele,et al. 18-Fluorine Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Infection in the Postoperative Spine , 2003, Spine.
[40] P E Ochsner,et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.
[41] D. Raoult,et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. , 1997, The Journal of antimicrobial chemotherapy.
[42] A. Widmer,et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. , 1994, The Journal of antimicrobial chemotherapy.
[43] S. Kunz,et al. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin , 1992, Antimicrobial Agents and Chemotherapy.